All the times Ackman's $1 billion bet against Herbalife should have been unwound - MarketWatch
Bill Ackman: Why Short Positions Are Difficult - YouTube
Billionaire's Fight Against Herbalife Would Work as Big Short Sequel – Andrew F. Quinlan
Bill Ackman, Pershing Made $2.7 Billion Hedging Rate Hikes: Quotes
The Greatest Trade Ever - YouTube
Billionaire Bill Ackman Dumps Herbalife, Ending 5-Year War Betting Against It
Bill Ackman makes US$2.5B 'recovery bet' amid coronavirus tumble - BNN Bloomberg
William Ackman: 'You Need a Thick Skin to Be in This Business' - The New York Times
Bill Ackman Lauds Hindenburg's Scathing Report On India's Adani As 'Highly Credible' — But Adds This Caveat
Bill Ackman - Investing Style and Track Record
Hedge-fund investor Bill Ackman says he's done with activist short-selling - MarketWatch
Bill Ackman Says He's Done with Activist Short Selling - Franknez.com
Judgment Day Has Come for Herbalife — and Bill Ackman Seems to Feel Just Fine
Billionaire Bill Ackman Dumps Herbalife, Ending 5-Year War Betting Against It
Herbalife Disputes Ackman's Claim of 'Pyramid Scheme'
Bill Ackman is finally cutting his losses on Herbalife
Ackman's Hong Kong short is logical, not likely | Reuters
Bill Ackman Herbalife Short Anniversary
Bill Ackman denies his 'hell is coming' warning was meant to stoke coronavirus fears | Daily Mail Online
Bill Ackman takes a hit from Herbalife short as stock soars
Bill Ackman Says Pershing Has Large Notional Short Position Against HK Dollar - BNN Bloomberg
Bill Ackman says his hedge fund has large short position against Hong Kong dollar | Seeking Alpha
Staking $1 Billion That Herbalife Will Fail, Then Lobbying to Bring It Down - The New York Times
Activist Investor Bill Ackman Plays Defense - WSJ
Bill Ackman says his CNBC interview was bullish, denies harming market
Bill Ackman Versus Herbalife: What Happened? | StreetFins®
Can Bill Ackman's Reputation Recover from the Valeant Mess? | Vanity Fair
How Herbalife's share buyback could force Bill Ackman to trim his short position - MarketWatch
